List of nationally authorised medicinal products
|
|
- Austen Owen
- 6 years ago
- Views:
Transcription
1 24 January 2018 EMA/270645/2015 Human Medicines Evaluation Division Active substance: azithromycin (systemic use formulations) Procedure no.: PSUSA/ / Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send a question via our website An agency of the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.
2 3Z, 150 mg, pó para suspensão oral National Number not available JABA RECORDATI, S.A. PT 3Z, 200 mg, pó para suspensão oral not available JABA RECORDATI, S.A. PT 3Z, 250 mg, pó para suspensão oral not available JABA RECORDATI, S.A. PT 3Z, 500 mg, pó para suspensão oral not available JABA RECORDATI, S.A. PT 3Z, 500 mg, pó para suspensão oral not available JABA RECORDATI, S.A. PT AZADOSE 600 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE FR AZADOSE 600 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE FR AZADOSE 600 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE FR AZADOSE 600 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE FR AZADOSE 600 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE FR EMA/24970/2018 Page 2/30
3 AZADOSE 600 mg, comprimé pelliculé National Number not available PFIZER HOLDING FRANCE FR Azatril 250 mg, filmcoated tablets NL/H/2400/ /2012/01-04 ACTAVIS GROUP PTC EHF. RO Azibiot 20 mg/ml milteliai geriamajai suspensijai SK/H/0148/003 LT/1/14/3600/003 KRKA, D.D., NOVO MESTO LT Azibiot 20 mg/ml pulbere pentru suspensie orală SK/H/0148/ /2017/01 KRKA, D.D., NOVO MESTO RO Azibiot NEO 20 mg/ml prášok na perorálnu suspenziu Azibiot, 20 mg/ml, proszek do sporządzania zawiesiny doustnej Azithromycin 250 mg Capsules SK/H/0148/003 15/0001/17-S KRKA, D.D., NOVO MESTO SK SK/H/0148/ KRKA, D.D., NOVO MESTO PL not available PL 42357/0224 AMNEAL PHARMA EUROPE UK LIMITED Azithromycin 250mg Tablets AT/H/0266/001 PL 04416/1235 SANDOZ LTD UK Azithromycin 500mg Tablets DE/H/1903/002 PL 04416/0668 SANDOZ LTD UK EMA/24970/2018 Page 3/30
4 Azithromycin Actavis 250 mg filmom obalené tablety Azithromycin Aurovitas 250 mg potahované tablety Azithromycin Aurovitas 500 mg potahované tablety Azithromycin Hexal 250 mg - Filmtabletten National Number NL/H/2400/001 15/0480/12-S ACTAVIS GROUP PTC EHF. SK PT/H/1475/001 15/481/16-C AUROVITAS UNIPESSOAL, LDA. PT/H/1475/002 15/482/16-C AUROVITAS UNIPESSOAL, LDA. AT/H/0266/ HEXAL PHARMA GMBH AT CZ CZ Azithromycin Krka 20 mg/ml pulveris iekšķīgi lietojamas suspensijas pagatavošanai Azithromycin Krka, 20 mg/ml suukaudse suspensiooni pulber Azithromycin Sandoz 100 mg/ 5 ml prášok na perorálnu suspenziu Azithromycin Sandoz 500 mg Filmtabletten SK/H/0148/ KRKA, D.D., NOVO MESTO LV SK/H/0148/ KRKA, D.D., NOVO MESTO EE NL/H/0886/001 15/0181/07-S SANDOZ PHARMACEUTICALS SK D.D. DE/H/1903/ SANDOZ GMBH AT Azithromycin Sandoz 500 mg - Granulat zur Herstellung einer AT/H/0390/ SANDOZ GMBH AT EMA/24970/2018 Page 4/30
5 Suspension zum Einnehmen auf einem Messlöffel Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès Azithromycin Sandoz 500 mg plèvele dengtos tabletès National Number DE/H/1903/002 LT/1/05/0323/007 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/010 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/008 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/009 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/011 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/012 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/013 SANDOZ GMBH LT DE/H/1903/002 LT/1/05/0323/014 SANDOZ GMBH LT EMA/24970/2018 Page 5/30
6 AZITHROMYCINE MONODOSE SANDOZ 250 mg, comprimé pelliculé AZITHROMYCINE SANDOZ 250 mg, comprimé pelliculé AZITHROMYCINE SANDOZ 250 mg, comprimé pelliculé AZITHROMYCINE SANDOZ 250 mg, comprimé pelliculé AZITHROMYCINE SANDOZ 250 mg, comprimé pelliculé Azitromax 2 g depotgranulat till oral suspension Azitromax 250 mg filmdragerade tabletter National Number not available SANDOZ FR not available SANDOZ FR not available SANDOZ FR not available SANDOZ FR not available SANDOZ FR not available PFIZER AB SE not available PFIZER AB SE Azitromax 40 mg/ml pulver till oral suspension not available PFIZER AB SE Azitromax 40 mg/ml, pulver til mikstur, suspensjon not available 8025 PFIZER AS NO EMA/24970/2018 Page 6/30
7 Azitromax 500 mg filmdragerade tabletter National Number not available PFIZER AB SE Azitromax 500 mg tabletter not available PFIZER AS NO Azitromax 500 mg, pulver till koncentrat till infusionsvätska, lösning Azitromax 600 mg filmdragerade tabletter not available PFIZER AB SE not available PFIZER AB SE Azitromicin Krka 20 mg/ml prašek za peroralno suspenzijo AZITROMICINA PFIZER 100 mg polvere per sospensione orale AZITROMICINA PFIZER 150 mg polvere per sospensione orale AZITROMICINA PFIZER 200 mg polvere per sospensione orale AZITROMICINA PFIZER 200 mg/5 ml polvere per sospensione orale SK/H/0148/003 H/14/00246/006 KRKA, D.D., NOVO MESTO SI not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT EMA/24970/2018 Page 7/30
8 AZITROMICINA PFIZER 200 mg/5 ml polvere per sospensione orale AZITROMICINA PFIZER 250 mg capsule rigide National Number not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT AZITROMICINA PFIZER 300 mg polvere per sospensione orale AZITROMICINA PFIZER 400 mg polvere per sospensione orale AZITROMICINA PFIZER 500 mg compresse rivestite con film AZITROMICINA PFIZER 500 mg polvere per soluzione per infusione AZITROMICINA PFIZER Avium 600 mg compresse rivestite con film Azitromicină Sandoz 500 mg, granule pentru suspensie orală în linguriță unidoză Azitromicina Teva 250 mg compresse rivestite con film not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT AT/H/0390/ /2012/01 S.C. SANDOZ S.R.L. RO NL/H/0614/ TEVA ITALIA S.R.L. IT EMA/24970/2018 Page 8/30
9 Azitromicina Teva 250 mg compresse rivestite con film Azitromicina Teva 250 mg compresse rivestite con film Azitromicina Teva 250 mg compresse rivestite con film Azitromicina TEVA 250 mg comprimidos recubiertos con pelicula EFG Azitromycine Sandoz 100 mg/5 ml, poeder voor orale suspensie ORDIPHA 500 mg, comprimé dispersible sécable ORDIPHA 500 mg, comprimé dispersible sécable Ribotrex 200 mg/5 ml polvere per sospensione orale Ribotrex 500 mg compresse rivestite con film National Number NL/H/0614/ TEVA ITALIA S.R.L. IT NL/H/0614/ TEVA ITALIA S.R.L. IT NL/H/614/ TEVA ITALIA S.R.L. IT NL/H/0614/ TEVA PHARMA S.L.U ES NL/H/0886/001 RVG SANDOZ B.V. NL not available TONIPHARM FR not available TONIPHARM FR not available PIERRE FABRE PHARMA S.R.L. not available PIERRE FABRE PHARMA S.R.L. IT IT EMA/24970/2018 Page 9/30
10 SUMAMED 100 mg/5 ml milteliai geriamajai suspensijai Sumamed 100 mg/5 ml por sziruphoz National Number not available LT/1/94/0529/005 TEVA PHARMA B.V. LT not available OGYI-T-5272/03 TEVA GYÓGYSZERGYÁR ZRT HU Sumamed 100 mg/5 ml prašak za oralnu suspenziju Sumamed 100 mg/5 ml pulveris iekšķīgi lietojamas suspensijas pagatavošanai Sumamed 100 mg/ml por oldatos infúzióhoz való koncentrátumhoz Sumamed 1200, 200 mg/5 ml prašak za oralnu suspenziju Sumamed 125 mg comprimate filmate not available HR-H PLIVA HRVATSKA D.O.O. HR not available TEVA PHARMA B.V. LV not available OGYI-T-5272/07 TEVA GYÓGYSZERGYÁR ZRT HU not available HR-H PLIVA HRVATSKA D.O.O. HR not available 8765/2016/01 PLIVA LJUBLJANA D.O.O.; RO Sumamed 125 mg filmom obalené tablety not available 15/0351/92-C/S TEVA PHARMACEUTICALS SLOVAKIA S.R.O SK Sumamed 125 mg filmom obložene tablete not available HR-H PLIVA HRVATSKA D.O.O. HR EMA/24970/2018 Page 10/30
11 SUMAMED 125 mg filmsko obložene tablete National Number not available H/92/01472/001 PLIVA LJUBLJANA D.O.O.; SI SUMAMED 125 mg potahované tablety not available A-C TEVA PHARMACEUTICALS CR, S.R.O. CZ Sumamed 1500, 200 mg/5 ml prašak za oralnu suspenziju Sumamed 250 mg capsule not available HR-H PLIVA CROATIA LTD HR not available 730/2008/01 PLIVA LJUBLJANA D.O.O.; RO Sumamed 250 mg cietās kapsulas not available TEVA PHARMA B.V. LV SUMAMED 250 mg kapsule not available HR-H TEVA B.V HR Sumamed 250 mg kemény kapszula not available OGYI-T-5272/04 TEVA GYÓGYSZERGYÁR ZRT HU Sumamed 250 mg kietosios kapsulės not available LT/1/94/0529/002 TEVA PHARMA B.V. LT SUMAMED 250 mg trde kapsule not available H/92/01472/002 PLIVA LJUBLJANA D.O.O.; SI EMA/24970/2018 Page 11/30
12 SUMAMED 40 mg/ml prašek za peroralno suspenzijo Sumamed 500 mg apvalkotas tabletes National Number not available H/92/01472/006 PLIVA LJUBLJANA D.O.O.; SI not available TEVA PHARMA B.V. LV Sumamed 500 mg comprimate filmate not available 8766/2016/01 PLIVA LJUBLJANA D.O.O.; RO Sumamed 500 mg filmom obalené tablety not available 15/0351/92-C/S TEVA PHARMACEUTICALS SLOVAKIA S.R.O SK Sumamed 500 mg filmom obložene tablete not available HR-H PLIVA CROATIA LTD HR SUMAMED 500 mg filmsko obložene tablete not available H/92/01472/003 PLIVA LJUBLJANA D.O.O.; SI Sumamed 500 mg filmtabletta not available OGYI-T-5272/05 TEVA GYÓGYSZERGYÁR ZRT HU SUMAMED 500 mg infuze prášek pro infuzní roztok not available 15/223/03-C TEVA PHARMACEUTICALS CR, S.R.O. CZ Sumamed 500 mg plėvele dengtos tabletės not available LT/1/94/0529/004 TEVA PHARMA B.V. LT EMA/24970/2018 Page 12/30
13 Sumamed 500 mg plėvele dengtos tabletės National Number not available LT/1/94/0529/003 TEVA PHARMA B.V. LT SUMAMED 500 mg potahované tablety not available 15/351/92-B/C TEVA PHARMACEUTICALS CR, S.R.O. CZ Sumamed 500 mg prašak za koncentrat za otopinu za infuziju SUMAMED 500 mg prašek za raztopino za infundiranje Sumamed forte 200 mg/5 ml milteliai geriamajai suspensijai Sumamed forte 200 mg/5 ml milteliai geriamajai suspensijai Sumamed forte 200 mg/5 ml milteliai geriamajai suspensijai Sumamed forte 200 mg/5 ml por sziruphoz not available HR-H PLIVA HRVATSKA D.O.O. HR not available H/92/01472/007 PLIVA LJUBLJANA D.O.O.; SI not available LT/1/94/0529/007 TEVA PHARMA B.V. LT not available LT/1/94/0529/006 TEVA PHARMA B.V. LT not available LT/1/94/0529/008 TEVA PHARMA B.V. LT not available OGYI-T-5272/02 TEVA GYÓGYSZERGYÁR ZRT HU Sumamed forte 200 mg/5 ml por sziruphoz not available OGYI-T-5272/08 TEVA GYÓGYSZERGYÁR ZRT HU EMA/24970/2018 Page 13/30
14 Sumamed forte 200 mg/5 ml prašak za oralnu suspenziju Sumamed forte 200 mg/5 ml prašak za oralnu suspenziju Sumamed Forte 200 mg/5 ml pulbere pentru suspensie orală Sumamed forte 200 mg/5 ml pulveris iekškigi lietojamas suspensijas pagatavošanai Sumamed forte prášok na sirup National Number not available HR-H PLIVA HRVATSKA D.O.O. HR not available HR-H PLIVA HRVATSKA D.O.O. HR not available 8767/2016/ PLIVA LJUBLJANA D.O.O.; RO not available TEVA PHARMA B.V. LV not available 15/0352/92-C/S TEVA PHARMACEUTICALS SLOVAKIA S.R.O SK SUMAMED forte sirup prášek pro perorální suspenzi SUMAMED FORTE, 200 mg/5 ml suukaudse suspensiooni pulber SUMAMED forte, 200 mg/5 ml, proszek do sporządzania zawiesiny doustnej not available 15/352/92-B/C TEVA PHARMACEUTICALS CR, S.R.O. CZ not available TEVA PHARMA B.V. EE not available 7422 TEVA PHARMACEUTICALS PL POLSKA SP. Z O.O. EMA/24970/2018 Page 14/30
15 Sumamed prášok na sirup National Number not available 15/0352/92-C/S TEVA PHARMACEUTICALS SLOVAKIA S.R.O SK Sumamed S 500 mg filmom obložene tablete not available HR-H PLIVA HRVATSKA D.O.O. HR SUMAMED S 500 mg filmsko obložene tablete not available H/92/01472/004 PLIVA LJUBLJANA D.O.O.; SI Sumamed S 500 mg filmtabletta not available OGYI-T-5272/06 TEVA GYÓGYSZERGYÁR ZRT HU SUMAMED sirup prášek pro perorální suspenzi not available 15/352/92-A/C TEVA PHARMACEUTICALS CR, S.R.O. CZ SUMAMED STD potahované tablety not available 15/249/02-C TEVA PHARMACEUTICALS CR, S.R.O. CZ Sumamed tvrdé kapsuly not available 15/0226/90-C/S TEVA PHARMACEUTICALS SLOVAKIA S.R.O SK SUMAMED tvrdé tobolky not available 15/226/90-C TEVA PHARMACEUTICALS CR, S.R.O. CZ SUMAMED za otroke 20 mg/ml prašek za peroralno suspenzijo not available H/92/01472/005 PLIVA LJUBLJANA D.O.O.; SI EMA/24970/2018 Page 15/30
16 SUMAMED, 100 mg/5 ml suukaudse suspensiooni pulber SUMAMED, 100 mg/5 ml, proszek do sporządzania zawiesiny doustnej Sumamed, 125 mg, tabletki powlekane National Number not available TEVA PHARMA B.V. EE not available 7421 TEVA PHARMACEUTICALS POLSKA SP. Z O.O. not available 8462 TEVA PHARMACEUTICALS POLSKA SP. Z O.O. PL PL SUMAMED, 250 mg kõvakapslid not available TEVA PHARMA B.V. EE Sumamed, 250 mg, kapsułki twarde not available 7423 TEVA PHARMACEUTICALS POLSKA SP. Z O.O. PL SUMAMED, 500 mg õhukese polümeerikattega tabletid SUMAMED, 500 mg, proszek do sporządzania roztworu do infuzji Sumamed, 500 mg, tabletki powlekane not available TEVA PHARMA B.V. EE not available 9016 TEVA PHARMACEUTICALS PL POLSKA SP. Z O.O. not available 7424 TEVA PHARMACEUTICALS PL POLSKA SP. Z O.O. TROZOCINA 2 g granulato per sospensione orale a rilascio prolungato not available SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. IT EMA/24970/2018 Page 16/30
17 TROZOCINA 200 mg/5 ml polvere per sospensione orale TROZOCINA 200 mg/5 ml polvere per sospensione orale TROZOCINA 250 mg capsule rigide TROZOCINA 500 mg compresse rivestite con film TROZOCINA 500 mg polvere per soluzione per infusione TROZOCINA Avium 600 mg compresse rivestite con film Ultreon 600 mg Filmtabletten National Number not available SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. IT not available SIGMA-TAU INDUSTRIE IT FARMACEUTICHE RIUNITE S.P.A. not available SIGMA-TAU INDUSTRIE IT FARMACEUTICHE RIUNITE S.P.A. not available SIGMA-TAU INDUSTRIE IT FARMACEUTICHE RIUNITE S.P.A. not available SIGMA-TAU INDUSTRIE IT FARMACEUTICHE RIUNITE S.P.A. not available SIGMA-TAU INDUSTRIE IT FARMACEUTICHE RIUNITE S.P.A. not available PFIZER PHARMA PFE GMBH DE Zetamax, 2 g, granulat o PT/H/0146/ PFIZER EUROPE MA EEIG PL przedłużonym uwalnianiu do sporządzania zawiesiny doustnej ZITHROMAX not available PFIZER HELLAS, A.E. CY EMA/24970/2018 Page 17/30
18 Zithromax 2 g granulado de libertação prolongada para suspensão oral Zithromax 2 g granulado de libertação prolongada para suspensão oral Zithromax 200 mg in 5 ml suspension National Number PT/H/0146/ LABORATÓRIOS PFIZER, LDA. PT/H/0146/ LABORATÓRIOS PFIZER, LDA. not available MA505/03901 PFIZER HELLAS, A.E. MT PT PT Zithromax 200 mg in 5 ml suspension not available PL 00057/0336 PFIZER LIMITED UK Zithromax 200 mg/5 ml - Trockensaft ZITHROMAX 200 mg/5 ml κόνις για πόσιμο εναιώρημα ZITHROMAX 200 mg/5ml κόνις για πόσιμο εναιώρημα ZITHROMAX 250 mg CAPSULES not available PFIZER CORPORATION AUSTRIA GESELLSCHAFT M.B.H. AT not available 41167/10/ PFIZER HELLAS, A.E. GR not available PFIZER HELLAS, A.E. CY not available MA505/03902 PFIZER HELLAS, A.E. MT ZITHROMAX 250 mg CAPSULES not available PL 00057/0335 PFIZER LIMITED UK EMA/24970/2018 Page 18/30
19 ZITHROMAX 250 mg filmdragerade tabletter azitromycin Zithromax 250 mg tabletti, kalvopäällysteinen ZITHROMAX 250 mg επικαλυμμένα με λεπτό υμένιο δισκία ZITHROMAX 250 mg καψάκια σκληρά National Number not available PFIZER OY FI not available PFIZER OY FI not available 44407/ PFIZER HELLAS, A.E. GR not available 44405/ PFIZER HELLAS, A.E. GR ZITHROMAX 250 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE (S.C.A.) FR ZITHROMAX 250 mg, comprimé pelliculé not available PFIZER HOLDING FRANCE (S.C.A.) FR Zithromax 250, tabletten 250 mg not available RVG PFIZER B.V. NL ZITHROMAX 40 mg/ml ENFANTS, poudre pour suspension buvable ZITHROMAX 40 mg/ml ENFANTS, poudre pour suspension buvable not available PFIZER HOLDING FRANCE FR not available PFIZER HOLDING FRANCE FR EMA/24970/2018 Page 19/30
20 ZITHROMAX 40 mg/ml ENFANTS, poudre pour suspension buvable ZITHROMAX 40 mg/ml ENFANTS, poudre pour suspension buvable Zithromax 40 mg/ml jauhe oraalisuspensiota varten Zithromax 40 mg/ml pó para suspensão oral National Number not available PFIZER HOLDING FRANCE FR not available PFIZER HOLDING FRANCE FR not available PFIZER OY FI not available LABORATÓRIOS PFIZER, LDA. PT Zithromax 40 mg/ml pó para suspensão oral not available LABORATÓRIOS PFIZER, LDA. PT Zithromax 40 mg/ml pó para suspensão oral not available LABORATÓRIOS PFIZER, LDA. PT Zithromax 40 mg/ml pó para suspensão oral not available LABORATÓRIOS PFIZER, LDA. PT ZITHROMAX 40 mg/ml pulver till oral suspension azitromycin Zithromax 500 mg - Filmtabletten not available PFIZER OY FI not available PFIZER CORPORATION AT AUSTRIA GESELLSCHAFT M.B.H. EMA/24970/2018 Page 20/30
21 Zithromax 500 mg comprimido revestido por película Zithromax 500 mg comprimido revestido por película ZITHROMAX 500 mg filmdragerade tabletter azitromycin Zithromax 500 mg tabletti, kalvopäällysteinen ZITHROMAX 500 mg επικαλυμμένα με λεπτό υμένιο δισκία Zithromax 500, tabletten 500 mg National Number not available LABORATÓRIOS PFIZER, LDA. not available LABORATÓRIOS PFIZER, LDA. not available PFIZER OY FI not available PFIZER OY FI not available 44409/ PFIZER HELLAS, A.E. GR not available RVG PFIZER B.V. NL PT PT Zithromax Capsules 250 mg not available PA 19/47/1 PFIZER LIMITED IE Zithromax i.v. 500 mg Pulver zur Herstellung einer Infusionslösung Zithromax IV 500 mg infuusiokuiva-aine, liuosta varten not available PFIZER CORPORATION AUSTRIA GESELLSCHAFT M.B.H. AT not available PFIZER OY FI EMA/24970/2018 Page 21/30
22 Zithromax IV 500 mg pó para solução para perfusão Zithromax IV 500 mg pó para solução para perfusão ZITHROMAX IV 500 mg pulver till infusionsvätska, lösning azitromycin ZITHROMAX MONODOSE 250 mg, comprimé pelliculé ZITHROMAX MONODOSE 250 mg, comprimé pelliculé Zithromax Powder for Oral Suspension 200 mg/5 ml ZITHROMAX, 500mg/φιαλίδιο, κόνις για διάλυμα προς έγχυση Zithromax, suspensie (poeder voor) 200 mg/5 ml Zithromax 250 mg Filmtabletten National Number not available LABORATÓRIOS PFIZER, LDA. not available LABORATÓRIOS PFIZER, LDA. not available PFIZER OY FI not available PFIZER HOLDING FRANCE (S.C.A.) not available PFIZER HOLDING FRANCE (S.C.A.) not available PA 19/47/2 PFIZER LIMITED IE not available 44411/ PFIZER HELLAS, A.E. GR not available RVG PFIZER B.V. NL not available PFIZER PHARMA PFE GMBH DE PT PT FR FR EMA/24970/2018 Page 22/30
23 Zithromax 500 mg Filmtabletten National Number not available PFIZER PHARMA PFE GMBH DE Zithromax i.v. 500 mg Pulver zur Herstellung einer Infusionslösung Zithromax Trockensaft 200 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen Zitinn 250 mg filmtabletta not available PFIZER PHARMA PFE GMBH DE not available PFIZER PHARMA PFE GMBH DE NL/H/2400/001 OGYI-T-22373/01-04 ACTAVIS GROUP PTC EHF. HU Zitrocin 100 mg/5 ml por sziruphoz not available OGYI-T-9027/03 TEVA MAGYARORSZÁG ZRT HU Zitrocin 250 mg kemény kapszula not available OGYI-T-9027/04 TEVA GYÓGYSZERGYÁR ZRT HU Zitrocin 500 mg filmtabletta not available OGYI-T-9027/05 TEVA GYÓGYSZERGYÁR ZRT HU Zitrocin forte 200 mg/5 ml por sziruphoz not available OGYI-T-9027/02 TEVA GYÓGYSZERGYÁR ZRT HU Zitrocin forte 200 mg/5 ml por sziruphoz not available OGYI-T-9027/07 TEVA GYÓGYSZERGYÁR ZRT HU EMA/24970/2018 Page 23/30
24 Zitrocin S 500 mg filmtabletta National Number not available OGYI-T-9027/06 TEVA GYÓGYSZERGYÁR ZRT HU ZITROMAX 100 mg polvere per sospensione orale ZITROMAX 1000 mg polvo para suspensión oral en sobre ZITROMAX 150 mg polvere per sospensione orale ZITROMAX 2 g granulato per sospensione orale a rilascio prolungato ZITROMAX 200 mg polvere per sospensione orale ZITROMAX 200 mg/5 ml Poeder voor orale suspensie ZITROMAX 200 mg/5 ml polvere per sospensione orale ZITROMAX 200 mg/5 ml polvere per sospensione orale not available PFIZER ITALIA S.R.L. IT not available PFIZER, S.L. ES not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available BE PFIZER S.A. (BELGIUM) BE not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT EMA/24970/2018 Page 24/30
25 ZITROMAX 200 mg/5 ml polvere per sospensione orale ZITROMAX 200 mg/5 ml polvere per sospensione orale ZITROMAX 200 mg/5 ml polvo para suspensión oral en frasco ZITROMAX 200 mg/5 ml Poudre pour suspension buvable Zitromax 200 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen Zitromax 200 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen Azithromycin ZITROMAX 200 mg/5ml Poudre pour suspension buvable ZITROMAX 250 mg cápsulas duras National Number not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available PFIZER, S.L. ES not available PFIZER S.A. (BELGIUM) LU not available BE PFIZER S.A. (BELGIUM) BE not available PFIZER S.A. (BELGIUM) LU not available BE PFIZER S.A. (BELGIUM) BE not available PFIZER, S.L. ES EMA/24970/2018 Page 25/30
26 ZITROMAX 250 mg capsule rigide National Number not available PFIZER ITALIA S.R.L. IT ZITROMAX 250 mg Comprimés pelliculés not available BE PFIZER S.A. (BELGIUM) BE ZITROMAX 250 mg Comprimés pelliculés not available PFIZER S.A. (BELGIUM) LU ZITROMAX 250 mg Filmomhulde tabletten not available BE PFIZER S.A. (BELGIUM) BE Zitromax 250 mg Filmtabletten not available BE PFIZER S.A. (BELGIUM) BE Zitromax 250 mg Filmtabletten Azithromycin Zitromax 250 mg filmuhúðaðar töflur not available PFIZER S.A. (BELGIUM) LU not available PFIZER APS IS ZITROMAX 250 mg polvo para suspensión oral en sobre ZITROMAX 300 mg polvere per sospensione orale not available PFIZER, S.L. ES not available PFIZER ITALIA S.R.L. IT EMA/24970/2018 Page 26/30
27 Zitromax 40 mg/ml mixtúruduft, dreifa National Number not available PFIZER APS IS ZITROMAX 400 mg polvere per sospensione orale ZITROMAX 500 mg compresse rivestite con film ZITROMAX 500 mg Comprimés pelliculés not available PFIZER ITALIA S.R.L. IT not available PFIZER ITALIA S.R.L. IT not available BE PFIZER S.A. (BELGIUM) BE ZITROMAX 500 mg Comprimés pelliculés not available PFIZER S.A. (BELGIUM) LU ZITROMAX 500 mg comprimidos recubiertos con película ZITROMAX 500 mg Filmomhulde tabletten not available PFIZER, S.L. ES not available BE PFIZER S.A. (BELGIUM) BE Zitromax 500 mg Filmtabletten not available BE PFIZER S.A. (BELGIUM) BE Zitromax 500 mg Filmtabletten Azithromycin not available PFIZER S.A. (BELGIUM) LU EMA/24970/2018 Page 27/30
28 Zitromax 500 mg filmuhúðaðar töflur National Number not available PFIZER APS IS Zitromax 500 mg innrennslisstofn, lausn not available IS/1/02/106/01 PFIZER APS IS ZITROMAX 500 mg polvere per soluzione per infusione ZITROMAX 500 mg polvo para solución para perfusión ZITROMAX 500 mg polvo para suspensión oral en sobre ZITROMAX 600 mg Comprimés pelliculés not available PFIZER ITALIA S.R.L. IT not available PFIZER, S.L. ES not available PFIZER, S.L. ES not available BE PFIZER S.A. (BELGIUM) BE ZITROMAX 600 mg Comprimés pelliculés not available PFIZER S.A. (BELGIUM) LU ZITROMAX 600 mg Filmomhulde tabletten not available BE PFIZER S.A. (BELGIUM) BE Zitromax 600 mg Filmtabletten not available BE PFIZER S.A. (BELGIUM) BE EMA/24970/2018 Page 28/30
29 Zitromax 600 mg Filmtabletten Azithromycin ZITROMAX Avium 600 mg compresse rivestite con film Zitromax UNO forðakyrni fyrir mixtúru, dreifu National Number not available PFIZER S.A. (BELGIUM) LU not available PFIZER ITALIA S.R.L. IT not available IS/1/05/134/01 PFIZER APS IS Zitromax UNO, depotgranulat til oral suspension Zitromax, filmovertrukne tabletter not available PFIZER APS DK not available PFIZER APS DK Zitromax, filmovertrukne tabletter not available PFIZER APS DK Zitromax, filmovertrukne tabletter not available PFIZER APS DK Zitromax, Pulver til koncentrat til infusionsvæske, opløsning Zitromax, pulver til oral suspension not available PFIZER APS DK not available PFIZER APS DK EMA/24970/2018 Page 29/30
30 Zmax 2 g retard granulátum belsőleges szuszpenzióhoz Азибиот 20 mg/ml прах за перорална суспензия National Number PT/H/0146/001 OGYI-T-20770/01 PFIZER KFT. HU SK/H/0148/ KRKA, D.D., NOVO MESTO BG Зимакс 2 g гранули с удължено освобождаване за перорална суспензия Сумамед 250 mg капсули, твърди not available PFIZER EUROPE MA EEIG BG not available ECOPHARM GROUP BG СУМАМЕД 500 mg прах за инфузионен разтвор not available TEVA PHARMACEUTICALS BULGARIA EOOD BG Сумамед 500 mg филмирани таблетки not available ECOPHARM GROUP BG Сумамед сироп 100mg/5ml прах за перорална суспензия Сумамед форте сироп 200mg/5ml прах за перорална суспензия not available ECOPHARM GROUP BG not available ECOPHARM GROUP BG EMA/24970/2018 Page 30/30
List of nationally authorised medicinal products
1 December 2016 EMA/750653/2016 Human Medicines Evaluation Division Active substance: valganciclovir Procedure no.: PSUSA/00003089/201603 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
12 April 2018 EMA/223740/2018 Human Medicines Evaluation Division Active substance: fludarabine Procedure no.: PSUSA/00001406/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
01 December 2016 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00002591/201604 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile
More informationList of nationally authorised medicinal products
12 April 2018 EMA/231137/2018 Human Medicines Evaluation Division Active substance: fluvoxamine Procedure no.: PSUSA/00001458/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
12 January 2017 EMA/36356/2017 Human Medicines Evaluation Division Active substance: hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine Procedure no.: PSUSA/00001696/201605
More informationList of nationally authorised medicinal products
06 July 2017 EMA/436040/2017 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00001815/201610 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20
More informationList of nationally authorised medicinal products
12 April 2018 EMA/243033/2018 Human Medicines Evaluation Division Active substance: fenofibrate Procedure no.: PSUSA/00001362/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
27 October 2016 EMA/719205/2016 Human Medicines Evaluation Division Active substance: ethinylestradiol / gestodene (except for transdermal application) Procedure no.: PSUSA/00001308/201603 30 Churchill
More informationList of nationally authorised medicinal products
12 April 2018 EMA/382206/2018 Human Medicines Evaluation Division Active substance(s): naproxen Procedure No.: PSUSA/00002125/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
30 November 2017 EMA/817337/2017 Human Medicines Evaluation Division Active substance: Itraconazole Procedure no.: PSUSA/00001798/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
30 November 2017 EMA/795271/2017 Human Medicines Evaluation Division Active substance: vinorelbine Procedure no.: PSUSA/00003124/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
10 September 2015 EMA/677092/2015 Procedure Management and Committees Support Active substance: glatiramer Procedure no.: PSUSA/00001529/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
17 May 2018 EMA/303456/2018 Human Medicines Evaluation Division Active substance: bromazepam Procedure no.: PSUSA/00000435/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
29 September 2017 EMA/658556/2017 Procedure Management and Committees Support Active substance: loratadine Procedure no.: PSU/00001907/201702 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
6 September 2018 EMA/608492/2018 Human Medicines Evaluation Division Active substance: betahistine Procedure no.: PSUSA/00000389/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
21 February 2018 EMA/208334/2018 Human Medicines Evaluation Division Active substance: ibuprofen / pseudoephedrine Procedure no.: PSUSA/00001711/201707 30 Churchill Place Canary Wharf London E14 5EU United
More informationList of nationally authorised medicinal products
28 September 2017 EMA/639167/2017 Human Medicines Evaluation Division Active substance: zanamivir Procedure no.: PSUSA/00003141/201701 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
21 June 2017 EMA/610895/2017 Human Medicines Evaluation Division Active substance: felbamate Procedure no.: PSUSA/00010155/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
6 September 2018 EMA/619619/2018 Human Medicines Evaluation Division Active substance: haemophilus influenzae / klebsiella ozaenae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus
More informationList of nationally authorised medicinal products
5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
30 November 2017 EMA/806830/2017 Human Medicines Evaluation Division Active substance: piroxicam Procedure no.: PSUSA/00002438/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
6 September 2018 EMA/615391/2018 Human Medicines Evaluation Division Active substance: tobramycin (nebuliser solution) (apart from centrally authorised product) Procedure no.: PSUSA/00009316/201712 30
More informationList of nationally authorised medicinal products
8 March 2018 EMA/182668/2018 Human Medicines Evaluation Division Active substance(s): triamcinolone (topical and nasal formulations) Procedure No.: PSUSA/00003017/201707 30 Churchill Place Canary Wharf
More informationList of nationally authorised medicinal products
29 November 2018 EMA/880324/2018 Human Medicines Evaluation Division Active substance: enalapril Procedure no.: PSUSA/00001211/201803 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
08 March 2018 EMA/170163/2018 Human Medicines Evaluation Division Active substance: enalapril / hydrochlorothiazide Procedure no.: PSUSA/00001212/201707 30 Churchill Place Canary Wharf London E14 5EU United
More informationList of nationally authorised medicinal products
09 June 2017 EMA/36849/2017 Human Medicines Evaluation Division Active substance(s): brimonidine / timolol Procedure No.: PSUSA/00000431/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
11 October 2017 EMA/784453/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): ipratropium / salbutamol Procedure No.: PSUSA/00001781/201701 30
More informationList of nationally authorised medicinal products
26 October 2017 EMA/690754/2017 Human Medicines Evaluation Division Active substance: fish oil / olive oil / soybean oil / triglycerides mediumchain Procedure no.: PSUSA/00010223/201702 30 Churchill Place
More informationList of nationally authorised medicinal products
11 September 2017 EMA/604559/2017 Human Medicines Evaluation Division Active substance: iron / parenteral preparations Procedure no.: PSUSA/00010236/201701 30 Churchill Place Canary Wharf London E14 5EU
More informationList of nationally authorised medicinal products
1 September 2017 EMA/580096/2017 Human Medicines Evaluation Division Active substance: terbutaline Procedure no.: PSUSA/00002897/201612 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
11 October 2017 EMA/691535/2017 Human Medicines Evaluation Division Active substance: Haemophilus type b conjugate vaccines Procedure no.: PSUSA/00001584/201702 30 Churchill Place Canary Wharf London E14
More informationList of nationally authorised medicinal products
10 September 2015 EMA/612853/2015 Procedure Management and Committees Support Active substance: tobramycin (nebuliser solution) Procedure no.: PSUSA/00009316/201412 30 Churchill Place Canary Wharf London
More informationList of nationally authorised medicinal products
20 July 2016 EMA/270645/2015 Procedure Management and Committees Support Active substance: apomorphine Procedure no.: PSUSA/00000227/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
11 January 2018 EMA/24585/2018 Human Medicines Evaluation Division Active substance: esomeprazole / naproxen Procedure no.: PSUSA/00001270/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
14 April 2016 EMA/284169/2016 Procedure Management and Committees Support Active substance: influenza vaccine (split virion, inactivated) (non centrally products) Procedure no.: PSUSA/00010298/201508 30
More informationList of nationally authorised medicinal products
28 September 2017 EMA/658449/2017 Human Medicines Evaluation Division Active substance: olodaterol Procedure no.: PSUSA/00010245/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationList of nationally authorised medicinal products
8 November 2017 EMA/845743/2017 Human Medicines Evaluation Division Active substance: ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus) Procedure no.: PSUSA/00010345/201702 30 Churchill
More informationList of nationally authorised medicinal products
10 September 2015 EMA/622830/2015 Procedure Management and Committees Support Active substance: azelastine Procedure no.: PSUSA/00000277/201412 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ESMOCARD LYO 2500 mg powder for concentrate for solution for infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER ESMOCARD LYO 2500 mg powder for concentrate for solution for infusion Esmolol hydrochloride Read all of this leaflet carefully before you start using this medicine.
More informationList of nationally authorised medicinal products
30 November 2017 EMA/812360/2017 Human Medicines Evaluation Division Active substance(s): mupirocin Procedure No.: PSUSA/00002096/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationBIJSLUITER: INFORMATIE VOOR DE PATIËNT
BIJSLUITER: INFORMATIE VOOR DE PATIËNT Sitagliptine Teva 25 mg, filmomhulde tabletten Sitagliptine Teva 50 mg, filmomhulde tabletten Sitagliptine Teva 100 mg, filmomhulde tabletten Sitagliptin Read all
More informationList of nationally authorised medicinal products
12 July 2018 EMA/497430/2018 Human Medicines Evaluation Division Active substance: tafluprost / timolol Procedure no.: PSUSA/00010324/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationPackage leaflet: Information for the user. ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion
Package leaflet: Information for the user ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion Esmolol hydrochloride Read all of this leaflet carefully before you start using
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER OXALIPLATIN 5 MG/ML POWDER FOR SOLUTION FOR INFUSION (OXALIPLATIN)
PACKAGE LEAFLET: INFORMATION FOR THE USER OXALIPLATIN 5 MG/ML POWDER FOR SOLUTION FOR INFUSION (OXALIPLATIN) Read all of this leaflet carefully before you are given Oxaliplatin. - Keep this leaflet. You
More informationList of nationally authorised medicinal products
3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
13 September 2017 EMA/706786/2017 Human Medicines Evaluation Division Active substance: Octenidine dihydrochloride / phenoxyethanol Procedure no.: PSUSA/00002199/201701 30 Churchill Place Canary Wharf
More informationPackage leaflet: Information for the patient. Rapibloc 300 mg poeder voor oplossing voor infusie Rapibloc 600 mg poeder voor oplossing voor infusie
Package leaflet: Information for the patient Rapibloc 300 mg poeder voor oplossing voor infusie Rapibloc 600 mg poeder voor oplossing voor infusie Landiolol hydrochloride This medicine is subject to additional
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine.
More informationList of nationally authorised medicinal products
5 May 2017 EMA/288255/2017 Human Medicines Evaluation Division Active substance: pilocarpine (ophthalmic formulation) Procedure no.: PSUSA/00002410/201608 30 Churchill Place Canary Wharf London E14 5EU
More informationBIJSLUITER: INFORMATIE VOOR DE PATIËNT
PACKAGE LEAFLET 1 BIJSLUITER: INFORMATIE VOOR DE PATIËNT Cinacalcet 30 mg Teva, filmomhulde tabletten Cinacalcet 60 mg Teva, filmomhulde tabletten Cinacalcet 90 mg Teva, filmomhulde tabletten Cinacalcet
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Metfmin HCl Aurobindo 500 mg/ 850 mg/ 1000 mg, film-coated tablets metfmin hydrochlide Read all of this leaflet carefully befe you start taking this medicine.
More informationAnnex I. List of nationally authorised medicinal products and marketing authorisation applications
Annex I List of nationally authorised medicinal products and marketing authorisation applications 1 Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for
More informationList of nationally authorised medicinal products
7 July 2016 EMA/437334/2016 Procedure Management and Committees Support Division Active substance: Terazosin Procedure no.: PSUSA/00002895/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationList of nationally authorised medicinal products
11 February 2016 EMA/255959/2016 Procedure Management and Committees Support Active substance: calcitonin salmon, synthetic analogue of eel calcitonin Procedure No.: PSUSA/00000494/201506 30 Churchill
More information(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Austria Austria Bulgaria Bulgaria
More informationList of nationally authorised medicinal products
8 March 2018 EMA/182904/2018 Human Medicines Evaluation Division Active substance(s): fluticasone propionate / formoterol fumarate dihydrate Procedure No.: PSUSA/00010339/201707 30 Churchill Place Canary
More informationList of nationally authorised medicinal products
30 November 2017 EMA/817351/2017 Human Medicines Evaluation Division Active substance: Lidocaine / prilocaine (not centrally authorised product) Procedure no.: PSUSA/00001867/201703 30 Churchill Place
More informationPackage leaflet: Information for the patient. Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride
Package leaflet: Information for the patient Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because
More informationVersion: 0005 February 2008 powder for solution for infusion Replaces: 0004 July 2007 PACKAGE LEAFLET: INFORMATION FOR THE USER
Page: 1 Package Leaflet PACKAGE LEAFLET: INFORMATION FOR THE USER powder for solution for infusion Oxaliplatin Read all of this leaflet carefully before you start using this
More informationList of nationally authorised medicinal products
12 July 2018 EMA/462856/2018 Human Medicines Evaluation Division Active substance: econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide Procedure no.: PSUSA/00001195/201711
More informationPackage leaflet: Information for the user. Tadalafil teva 10 mg film-coated tablet Tadalafil teva 20 mg film-coated tablet tadalafil
Package leaflet: Information for the user Tadalafil teva 10 mg film-coated tablet Tadalafil teva 20 mg film-coated tablet tadalafil Read all of this leaflet carefully before you start taking this medicine
More informationList of nationally authorised medicinal products
6 September 2018 EMA/612350/2018 Human Medicines Evaluation Division Active substance: azelastine Procedure no.: PSUSA/00000277/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone
More informationANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTES OF ADMINISTRATION, APPLICANTS IN THE MEMBER STATES
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTES OF ADMINISTRATION, APPLICANTS IN THE MEMBER STATES 1 Member State EU/EEA Marketing Authorisation Holder Austria
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Simvastatin Aurobindo 5 mg film-coated tablets Simvastatin Aurobindo 10 mg film-coated tablets Simvastatin Aurobindo 20 mg film-coated tablets Simvastatin Aurobindo
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine
More information(DK/H/1774/001/R/001 Response on add CMS comments FRAR) OXALIPLATIN 150 MG; 50 MG POWDER FOR SOLUTION FOR INFUSION
Sandoz Business use only Page 1 of 10 Package leaflet: Information for the patient Oxaliplatin Ebewe 5mg/ml powder for solution for infusion Oxaliplatin Read all of this leaflet carefully before you are
More informationPublic administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government
More informationAnnex I. List of nationally authorised medicinal products and marketing authorisation applications
Annex I List of nationally authorised medicinal products and marketing authorisation applications 1 Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for
More informationPackage Leaflet. Package leaflet: Information for the patient
Sandoz Business use only Page 1 of 13 Package Leaflet Package leaflet: Information for the patient [Nationally completed name] 100 mg/5 ml powder for oral suspension [Nationally completed name] 200 mg/5
More informationPlease note that this draft Annex I will be updated to amend information on concerned products/mahs
22 March 2018 EMA/197481/2018 Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of, applicants, marketing authorisation holders in the member states for for omega-3
More informationPackage leaflet: Information for the user. Clopidogrel 75 mg film-coated tablets. Clopidogrel
Package leaflet: Information for the user Clopidogrel 75 mg film-coated tablets Clopidogrel Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Tevaquel 25 mg Film-coated Tablets Tevaquel 100 mg Film-coated Tablets Tevaquel 150 mg Film-coated Tablets Tevaquel 200 mg Film-coated Tablets Tevaquel 300
More information(Invented) Name. Crestor 5 mg Filmtabletten. Filmtabletten. Filmtabletten. Filmtabletten. Crestor 5 mg Film coated tablets Oral use
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, route of and marketing authorisation holders in the Member s 1 Austria Austria Austria Austria Belgium Belgium Belgium
More informationList of nationally authorised medicinal products
28 September EMA/662335/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): levosalbutamol, salbutamol Procedure No.: PSUSA/00010330/201701 30
More informationPackage leaflet: Information for the user. Gemcitabine Fresenius Kabi 40 mg/ml, concentraat voor oplossing voor infusie Gemcitabine
Package leaflet: Information for the user Gemcitabine Fresenius Kabi 40 mg/ml, concentraat voor oplossing voor infusie Gemcitabine Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Sevelamer Carbonate Rowex 800mg Film-coated tablets sevelamer carbonate Read all of this leaflet carefully before you start taking this medicine because it contains
More information4,0 g/0,5 g. 2g/250 mg. 4 g/500 mg. 4g/0,5g 2.25 G/VIAL. injection 4.5 G/VIAL. injection. injection
ANNEX I List of the names, pharmaceutical forms, strengths of the medicinal products, route of, marketing authorisation holders in the Member States 1 Route of ) Austria Bulgaria Cyprus Cyprus Czech Republic
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Etoricoxib
PACKAGE LEAFLET: INFORMATION FOR THE USER ARCOXIA 30 mg film-coated tablets ARCOXIA 60 mg film-coated tablets ARCOXIA 90 mg film-coated tablets ARCOXIA 120 mg film-coated tablets Etoricoxib Read all of
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. PEGLAX 10g Powder for oral solution in sachet. Macrogol 4000
PACKAGE LEAFLET: INFORMATION FOR THE USER PEGLAX 10g Powder for oral solution in sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Valaciclovir Teva 500 mg Film-coated Tablets. Valaciclovir
PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Teva 500 mg Film-coated Tablets Valaciclovir Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER 500 mg / 30 mg granules for oral suspension Acetylsalicylic acid / pseudoephedrine hydrochloride Read all of this leaflet carefully before you
More informationEUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008
European Medicines Agency Doc. Ref. EMEA/357907/2008 P/53/2008 EUROPEAN MEDICINES AGENCY DECISION of 20 July 2008 on the application for agreement of a Paediatric Investigation Plan for Atorvastatin calcium
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationPackage leaflet: information for the user
Package leaflet: information for the user Rosuvastatin 5 mg film-coated tablets Rosuvastatin 10 mg film-coated tablets Rosuvastatin 20 mg film-coated tablets Rosuvastatin 40 mg film-coated tablets rosuvastatin
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Arcoxia 60 mg Film coated Tablets Arcoxia 90 mg Film coated Tablets etoricoxib
PACKAGE LEAFLET: INFORMATION FOR THE USER Arcoxia 60 mg Film coated Tablets Arcoxia 90 mg Film coated Tablets etoricoxib Read all of this leaflet carefully before you start taking this medicine. Keep this
More informationSimvastatin Teva 10 mg Film-coated Tablets Simvastatin Teva 20 mg Film-coated Tablets Simvastatin Teva 40 mg Film-coated Tablets Simvastatin
PACKAGE LEAFLET: INFORMATION FOR THE USER Simvastatin Teva 10 mg Film-coated Tablets Simvastatin Teva 20 mg Film-coated Tablets Simvastatin Teva 40 mg Film-coated Tablets Simvastatin Read all of this leaflet
More informationImplementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO
Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'
More informationTadim 1 Million I.E. Pulver zur Herstellung einer Infusionslösung. Tadim 1 Million I.E. Pulver zur Herstellung einer Lösung für einen Vernebler
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration and marketing authorisation s in the member states 1 Austria Forest Pharma B.V. Newtonlaan
More informationList of nationally authorised medicinal products
12 April 2018 EMA/227889/2018 Human Medicines Evaluation Division Active substance(s): typhoid polysaccharide vaccine Procedure No.: PSUSA/00003065/201708 30 Churchill Place Canary Wharf London E14 5EU
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Atorvastatin 10 mg Film-coated Tablets Atorvastatin 20 mg Film-coated Tablets Atorvastatin 40 mg Film-coated Tablets Atorvastatin 80 mg Film-coated Tablets
More informationPACKAGE LEAFLET. Package leaflet: Information for the patient
PACKAGE LEAFLET Package leaflet: Information for the patient Etoricoxib 30 mg Film-coated tablets Etoricoxib 60 mg Film-coated tablets Etoricoxib 90 mg Film-coated tablets Etoricoxib120 mg Film-coated
More informationASPIRIN COMPLEX 500 mg / 30 mg Granules for Oral Suspension Acetylsalicylic Acid 500 mg, Pseudoephedrine Hydrochloride 30 mg
PACKAGE LEAFLET: INFORMATION FOR THE USER ASPIRIN COMPLEX 500 mg / 30 mg Granules for Oral Suspension Acetylsalicylic Acid 500 mg, Pseudoephedrine Hydrochloride 30 mg Read all of this leaflet carefully
More information(Invented) Name Strength Pharmaceutical form. Ergotop 10 mg - Tabletten. Ergotop 20 mg - Filmtabletten. Ergotop 30 mg - Filmtabletten
Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Bulgaria Bulgaria Czech Republic Kwizda Pharma
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Etoricoxib Teva 30 mg Film-coated Tablets Etoricoxib Teva 60 mg Film-coated Tablets Etoricoxib Teva 90 mg Film-coated Tablets Etoricoxib Teva 120 mg Film-coated
More informationInvented name Strength. 125mg/5ml. 250mg/5ml
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, route of administration, marketing authorisation holders in the Member States Member State (EU/EEA) Marketing Authorisation
More informationMarketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette
Annex I List of the names, pharmaceutical form, strengths of the medicinal products, route of, marketing authorisation holders in the Member States 1 Levonorgestrel-containing emergency contraceptive medicinal
More informationEUROPEAN CITIZENS DIGITAL HEALTH LITERACY
Flash Eurobarometer 404 EUROPEAN CITIZENS DIGITAL HEALTH LITERACY SUMMARY Fieldwork: September 2014 Publication: November 2014 This survey has been requested by the European Commission, Directorate-General
More information